MM
Meher Mohd Afzal Shaikh
About Meher Mohd Afzal Shaikh
Data last updated:
Meher Mohd Afzal Shaikh is a Director at Epitask Pharmaceuticals Private Limited (since 2022). The company operates in Pharma. Epitask Pharmaceuticals Private Limited reported revenue of ₹15 Lakh (FY 2018).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Epitask Pharmaceuticals Private Limited U24200MH2016PTC282170 | Director | 20 Aug 2022 | 2016 | ₹15 Lakh (FY 2018) | Active |
Board colleagues of Meher Mohd Afzal Shaikh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ikramullah Hafizullah Choudhary | 07522702 | Epitask Pharmaceuticals Private Limited | Director |
| Mohammed Afzal Mohammed Rafi Shaikh | 07501568 | Epitask Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Meher Mohd Afzal Shaikh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Meher Mohd Afzal Shaikh
Meher Mohd Afzal Shaikh currently holds 1 directorship: Epitask Pharmaceuticals Private Limited (Director, since 20 Aug 2022, revenue ₹15 Lakh (FY 2018)).
Meher Mohd Afzal Shaikh was first appointed on 20 Aug 2022 as Director at Epitask Pharmaceuticals Private Limited.
The current boards of Meher Mohd Afzal Shaikh's companies include Ikramullah Hafizullah Choudhary (Epitask Pharmaceuticals Private Limited), Mohammed Afzal Mohammed Rafi Shaikh (Epitask Pharmaceuticals Private Limited).